These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Experts confer on vasectomy and prostate cancer risk.
    Author: Bowersox J.
    Journal: J Natl Cancer Inst; 1993 Apr 07; 85(7):527-8. PubMed ID: 8095987.
    Abstract:
    In March 1993, physicians attended a US National Institutes of Health (NIH) conference on a possible association between vasectomy and prostate cancer. Participants learned that some studies have found an association while others have not. The strongest evidence of an association is a small association. The inconsistency of the results of various studies and the lack of a convincing biological mechanism satisfied participants that no need exists to recommend changes in clinical and public health practice. 2 recent, well-controlled studies, conducted by researchers at Brigham and Women's Hospital in Boston, Massachusetts, published in the Journal of the American Medical Association found around a 60% increase in risk of developing prostate cancer in men with vasectomies. It found a decreased risk for overall mortality among vasectomized men, however. These studies prompted a call for this NIH conference. Studies prior to these Boston studies had methodological flaws, especially detection bias. Specifically, urologists are more likely to examine men with vasectomies and, therefore, diagnose prostate cancer. A well-controlled, large-scale, case control study in California published in 1991 and its follow-up study did not find an increased risk of prostate cancer in vasectomized men. The follow-up study found a decreased risk for overall mortality among men with vasectomies. The lack of knowledge about the etiology of prostate cancer is the biggest roadblock to understanding the link between vasectomy and prostate cancer. Suggested mechanisms explaining vasectomy's ability to increase prostate cancer risk include changes in hormone levels, immunologic responses, and changes in levels of cancer-promoting growth factors or inhibitors of these factors.
    [Abstract] [Full Text] [Related] [New Search]